In the News
Wednesday, November 16, 2011 - 11:50
in Health & Medicine
After the success of protease inhibitors in HIV, research groups around the world began investigating whether the same mechanism would work for hepatitis C. In 1997 Charles M. Rice, now head of the laboratory of virology and infectious disease at the Rockefeller University, showed that mutating the viral protease in hepatitis C–infected chimpanzees stopped the virus, the first clue about the enzyme’s importance. More »